How a Top 20 Pharma Company Turned a Decade-Long Promotional Intelligence Partnership Into a Portfolio-Wide Decision Engine
A Decade of Partnership. One Decision Intelligence Platform. Portfolio-Wide Results.
When a Top 20 pharma company needed to know if its promotional spend was working, it didn't hire a consultant for a one-off study. It partnered with Axtria — and never stopped.
Ten-plus years later, that partnership has grown into something bigger than measurement. Axtria MarketingIQ™ now runs as a single, always-on decision engine across 5+ brands and 3+ therapy areas, replacing annual marketing mix modeling with continuous, monthly insight down to the HCP and DMA level.
The results speak for themselves:
- 70–80% of promotional spend now flows through model-driven recommendations
- 5–25% estimated ROI lift on reallocated channel spend
- 4–6 weeks faster response to mid-cycle performance signals
This isn't a dashboard bolted onto old habits. It's a platform that compounds — where every model, every dataset, every insight builds on the last, instead of resetting with every new project. Competitive benchmarking, cross-channel synergy analysis, and omnichannel pathway intelligence all live in one system, giving brand teams a single source of truth that now shows up in leadership planning reviews and QBRs.
The channels will keep changing. The question won't: is your promotional investment working as optimally as it should?
See what a decade-tested decision engine can do for your portfolio.
FAQs
Axtria MarketingIQTM is a decision intelligence platform that replaces fragmented marketing mix modeling environments with an always-on, portfolio-level promotional analytics capability for biopharma companies. It enables brand teams to measure and optimize promotional spend across DTC and HCP channels to drive stronger ROI.
Marketing mix modeling in pharma provides a unified measurement framework that shows how each channel—TV, digital, social, and HCP promotion—individually and collectively contributes to prescription lift across brands at different lifecycle stages. This replaces siloed reporting with portfolio-wide decision intelligence that scales across therapy areas.
Axtria partnered with this leading biopharma company for over a decade, expanding promotional intelligence coverage to 5+ brands across 3+ therapy areas in the US market. The engagement evolved from channel-level measurement into an enterprise decision engine powering omnichannel promotional optimization.
Axtria MarketingIQTM models a comprehensive channel mix including DTC television, display banners, online video, paid search, paid social, HCP personal promotion, and emerging channels such as short-form video and social discovery platforms. This breadth enables accurate attribution and spend optimization across the full omnichannel portfolio.
Without a unified promotional analytics solution, biopharma companies lack clear visibility into how channels perform in isolation and in combination, making it impossible to benchmark against competitors or optimize share of voice across a diverse brand portfolio. A decision intelligence platform like Axtria MarketingIQ™ solves this by delivering always-on, evidence-based insights that connect promotional investment to real commercial outcomes.
Recommended insights
Case Study
Case Study